Brian McKelligon insider trades: Akoya Biosciences (AKYA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | AKYA | ↓ Sell | 7,500 | $2.08 | $16K | Direct | Jun 12, 2024 (1d) |
| Jun 6, 2024 | AKYA | ↓ Sell | 7,500 | $2.01 | $15K | Direct | Jun 7, 2024 (1d) |
| Mar 20, 2024 | AKYA | ↓ Sell | 7,500 | $4.97 | $37K | Direct | Mar 22, 2024 (2d) |
| Mar 13, 2024 | AKYA | ↓ Sell | 7,500 | $4.94 | $37K | Direct | Mar 14, 2024 (1d) |
| Dec 19, 2023 | AKYA | ↓ Sell | 7,500 | $4.48 | $34K | Direct | Dec 20, 2023 (1d) |
| Dec 12, 2023 | AKYA | ↓ Sell | 7,500 | $4.25 | $32K | Direct | Dec 14, 2023 (2d) |
| Nov 20, 2023 | AKYA | ↓ Sell | 7,500 | $4.39 | $33K | Direct | Nov 22, 2023 (2d) |
| Jun 6, 2023 | AKYA | ↓ Sell | 5,000 | $5.71 | $29K | Direct | Jun 6, 2023 (0d) |
| Mar 14, 2023 | AKYA | ↓ Sell | 5,000 | $9.17 | $46K | Direct | Mar 16, 2023 (2d) |
| Dec 6, 2022 | AKYA | ↓ Sell | 5,000 | $12.08 | $60K | Direct | Dec 8, 2022 (2d) |
| Sep 7, 2022 | AKYA | ↓ Sell | 5,000 | $12.83 | $64K | Direct | Sep 9, 2022 (2d) |
| Jun 15, 2022 | AKYA | ↓ Sell | 5,000 | $10.25 | $51K | Direct | Jun 17, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Brian McKelligon's insider trades
Brian McKelligon is President and CEO at Akoya Biosciences (AKYA). Since Jun 15, 2022, Brian has reported no open-market purchases and 12 sales worth $454K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (11 filings), shares withheld for taxes (6 filings), grants and awards (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKYA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.